Cytotoxic effect of photodynamic therapy with photofrin II on intimai hyperplasia

Annals of Vascular Surgery

Volumn 10, Issue 3, 1996, Pages 273-282

  Eton, Darwin ^a,c,d,e   Shim, Veronica ^c   Maibenco, Thomas A ^a   Spero, Kenneth ^a   Cava, Raymond A ^a   Borhani, Martin ^a   Grossweiner, Leonard ^b   Ahn, Samuel S ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ADVOCATE HEALTH CARE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; EXTRACELLULAR MATRIX; LONG TERM CARE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RABBIT;

ANIMALS; BALLOON DILATATION; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CAROTID STENOSIS; DIHEMATOPORPHYRIN ETHER; HEMATOPORPHYRIN PHOTORADIATION; HYPERPLASIA; MICROSCOPY, ELECTRON; RABBITS; TIME FACTORS; TUNICA INTIMA;

EID: 0029894325     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02001893     Document Type: Article

References (13)

1. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-157.
2. Dartsch PC, Ischinger T, Betz E. Differential effect of Photophrin II on growth of human SM cells from non-atherosclerotic arteries and atheromatous plaques in vitro. Atherosclerosis 1990;10:616-621.
3. Dartsch PC, Ischinger T, Betz E. Responses of cultured SM cells from human nonatherosclerotic arteries and primary stenosing lesions after photoradiation: Implications for photodynamic therapy of vascular stenoses. J Am Coll Cardiol 1990;15:1545-1552.
4. Dartsch PC, Betz E, Ischinger T. Effect of dihematoporphyrin derivatives on cultivated human SM cells from normal and atherosclerotic vascular segments. Overview of results and implications for photodynamic therapy. Z Kardiol 1991;80:6-10.
5. Ortu P, LaMuraglia GM, Roberts G, et al. Photodynamic therapy of arteries: A novel approach for treatment of experimental intimal hyperplasia. Circulation 1992;85:1189-1196.
6. Eton D, Borhani R, Spero K, et al. Photodynamic therapy: Cytotoxicity of aluminum phthalocyanine on intimal hyperplasia. Arch Surg 1995;130:1098-1103.
7. Eton D, Ahn SS, Shim V, et al. Photodynamic therapy of intimal hyperplasia. J Surg Res 1992;53:558-562.
8. Hsiang Y, Houston G, Crespo T, et al. Preventing intimal hyperplasia with photodynamic therapy using an intravascular probe. Ann Vasc Surg 1995;9:80-86.
9. LaMuraglia GM, ChandraSekar NR, Flotte TJ, et al. Photodynamic therapy inhibition of experimental intimai hyperplasia: Acute and chronic effects. J Vasc Surg 1994;19:321-329.
10. Firey PA, Rodgers MAJ. Photoproperties of a silicon napthalocyanine: A potential photosensitizer for photodynamic therapy. Photochem Photobiol 1987;45:535-558.
11. Borland CF, McGarvey DJ, Truscott TG, et al. Photophysical studies of bacteriochlorophyllase and bacteriopheophytin a-singlet oxygen generation. J Photochem Photobiol B 1987;1: 93-101.
12. Reed MWR, Wieman TJ, Schuschke DA, et al. The response of the rat urinary bladder microcirculation to photodynamic therapy. J Urol 1989;142:865-868.
13. Hsiang Y. Concentration of P2 in MIH. Proceedings of the Twenty-first World Congress of the International Society for Cardiovascular Surgery, September 15, 1993, Lisbon, Portugal.